According to CNBC, after the close, several mid-cap names posted quarterly results that sparked outsized moves in after-hours trading. MillerKnoll led the declines, while Karman, Celcuity and Worthington Steel also traded on the back of their respective earnings reports. The quartet reflects a mix of consumer-facing durable goods, aerospace and defense exposure, biotech fundamentals and metals processing, with investors weighing earnings trajectories against cost pressures and near-term guidance.
MillerKnoll fell 14% after the furniture maker reported fiscal third-quarter adjusted earnings of 43 cents per share on revenue of $926.6 million. The results reflected a year-over-year decline of 2% in adjusted earnings despite a 6% uptick in revenue. Management warned of an approximately $8 million to $9 million impact to the fourth quarter tied to the ongoing Middle East conflict, noting minimal shipments to that region and higher logistics costs as key drags on margins and profitability.
Karman Aerospace & Defense saw its shares drift lower in relief after posting fiscal fourth-quarter adjusted earnings of 11 cents per share, missing the 12-cent consensus compiled by FactSet. Revenue came in at $134.5 million, above the $132.6 million street estimate. The uneven mix—softness in earnings alongside a better-than-expected top line—left investors digesting how order backlogs and program timing might shape profit in the year ahead.
Celcuity, a biotechnology firm, shed nearly 4% after reporting a fourth-quarter loss of 97 cents per share, which was narrower than the consensus of $1.04 per share per FactSet. Research and development expense of $37.6 million was in line with analysts’ expectations, providing some reassurance that cash burn and pipeline funding remained on track relative to forecasts.
Worthington Steel tumbled about 14% after posting fiscal third-quarter adjusted earnings of 27 cents per share, down from 35 cents in the year-ago period. The softer print underscored ongoing margin pressure in steel processing as the company grapples with input costs and pricing dynamics that have weighed on quarterly profitability.
Key takeaways
- Price move: MillerKnoll fell ~14% after-hours; Worthington Steel declined ~14%; Karman and Celcuity moved modestly or slightly lower to higher on their reports.
- Catalyst: MillerKnoll’s Q3 results and spiteful Q4 guidance tied to geopolitical cost pressures; Karman’s mixed top-line beat with a jaw-dropping EPS miss; Celcuity’s narrower loss versus consensus; Worthington’s softer quarterly earnings signal margin headwinds in steel processing.
- Key implication: The results highlight cost pressures (logistics, shipping) and the sensitivity of manufacturing and specialty metals to macro factors, while some names show resilience in revenue or a narrower loss, underscoring divergent paths within mid-cap equities.
What drove the move
MillerKnoll’s downshift appears anchored to its quarterly mix and the forward-looking impact of geopolitical tensions on logistics costs. With adjusted earnings retreating year over year and the company signaling a roughly $8 million to $9 million hit to Q4 from the Middle East conflict, investors are weighing the breadth of demand against higher transportation costs and potential shipment curtailments in key regions. The guidance read as a reminder that even relatively stable consumer demand for furniture can be vulnerable to global freight and route constraints, especially when demand is uneven across geographies.
Karman’s results paint a different rhythm: a fourth-quarter top-line beat against expectations contrasted with a first-line miss on adjusted earnings. The revenue outperformance suggests solid program activity or backlog execution, even as the market questions margin progression and the timing of defense-related orders. While the EPS miss is modest, it underscores how shifting cost structures and program timing can influence quarterly profitability, even during revenue strength.
Celcuity’s quarterly dynamics centered on the clearance path of a negative earnings print, albeit with a loss tighter than consensus. The firm’s R&D expense allocation remained in line with forecasts, providing some comfort that the pipeline funding remains intact. In biotechnology, even a smaller loss can be viewed positively if it accompanies stable or improving pipeline milestones, though the stock’s reaction suggests investors want more clarity on near-term clinical or regulatory catalysts.
Worthington Steel’s Q3 print put the focus on the pace of demand for metal processing services and the ability to sustain margins in a volatile input-cost environment. A drop in adjusted earnings from the prior year implies continued pricing and cost-pressure headwinds that could limit quarterly upside unless new contracts or productivity gains emerge.
What analysts are saying
Analysts’ takeaways centered on the relative strength or softness of earnings versus expectations and the implications for near-term guidance. In Karman’s case, FactSet consensus called for 12 cents in adjusted earnings, but the reported 11 cents marked a shortfall that investors weighed against the revenue beat. Celcuity’s quarterly loss, while narrower than anticipated, still leaves a negative earnings trajectory that analysts will monitor against clinical milestones and regulatory timelines. For MillerKnoll and Worthington Steel, the absence of a single-point consensus on the immediate guidance leaves traders focused on management commentary around costs, capacity utilization, and any anticipated pricing actions to offset ongoing logistics and material pressures.
Data shows that concerns around logistics costs and supply-chain stability have yet to fade, even as some companies leverage revenue strength to cushion earnings. Analysts will likely scrutinize whether the current cost environment is transitory or structurally embedded, and how that will shape the fourth-quarter and full-year outlooks for consumer-facing manufacturers and metal-processing firms alike.
Bigger picture
The quarterly set of results underscores a broader macro theme: cost inflation, especially in transportation and logistics, remains a critical headwind for mid-cap companies with mixed product lines. The Middle East conflict, though regional in scope, translates into global shipping cost pressures that can erode margins even when top-line growth persists. Investors are watching how management teams guide on margins, capacity, and inventory in an environment where macro signals—rates, inflation, and geopolitical developments—continue to influence demand, pricing power, and capital allocation decisions.
In sectors like furniture and durable goods, demand resilience can diverge sharply by product category and geography. In biotech, the emphasis shifts toward clinical milestones and burn management, as investors weigh near-term losses against longer-term pipeline value. For steel processing, the interplay between input costs, contract pricing, and utilization rates remains a focal point for margin recovery potential.
Overall, the post-earnings landscape illustrates how earnings quality and guidance can diverge even among companies reporting positive top-line trends. The market will likely reward clear, disciplined progress on cost control and backlog conversion, while punishing actions that leave margin trajectories uncertain.
What to watch next: Each company’s next set of communications—whether an updated outlook, conference call commentary, or new orders—will be pivotal. Investors will look for forward-looking margin targets, any shifts in shipments or backlog timing, and how macro factors—logistics costs, geopolitical risk, and inflation—are incorporated into guidance for the remainder of the year.
